News

U.S. Cymbalta cost highest in international comparison


 

The cost of duloxetine is considerably higher in the United States than in other industrialized countries, according to a report from the International Federation of Health Plans.

The average price for a 1-month supply of duloxetine (Cymbalta) was $176 in the United States, which is 56% higher than in Canada ($113) and 274% higher than in France, where the cost was lowest at $47, the IFHP said. Duloxetine is used to treat depression, anxiety, and pain.

The IFHP consists of more than 80 companies in 25 countries. For the survey, the price of duloxetine for each country was submitted by participating member plans. Some prices are drawn from the public sector, some from the private, and some from both. Estimates for the United States are aggregates based on over 100 million claims paid by multiple health plans.

rfranki@frontlinemedcom.com

Recommended Reading

Health exchanges could bring unpleasant surprises
MDedge Neurology
Battling over the budget: The Policy & Practice Podcast
MDedge Neurology
Providers order fewer tests when fees are listed
MDedge Neurology
More than 23% of uninsured didn't take medications as prescribed
MDedge Neurology
Storify: After Boston Marathon blasts, doctors rush to help
MDedge Neurology
Emergency physicians share lessons from Boston Marathon bombings response
MDedge Neurology
Lawmakers take aim at ACA implementation: The Policy & Practice podcast
MDedge Neurology
Supreme Court ponders patenting of human genes
MDedge Neurology
Navigating the new insurance exchanges
MDedge Neurology
Neurology shortfall to worsen by 2025
MDedge Neurology